Steen Riisgaard
President & CEO of Novozymes A/S
Steen Riisgaard has held the position as president and CEO since Novozymes was demerged from Novo Nordisk in 2000. Mr. Riisgaard joined Novo in 1979 as a microbiologist in Enzymes R&D. In 1982 he started up an Enzymes R&D unit in Novo's subsidiary, Novo Industri Japan Ltd. Prior to joining Novo Nordisk, Mr Riisgaard was a research fellow at the Serum Institute of Denmark (1976-77) and a research microbiologist at Foss Electric, Denmark. Riisgaard received his MSc in Biology from the University of Copenhagen. Mr Riisgaard serves on the boards of WWF (World Wildlife Fund) Denmark and Egmont International Holding A/S and he is the Chairman for EuropaBio.
